88 related articles for article (PubMed ID: 20079762)
21. Kv1.3 potassium channel-blocking toxin Ctri9577, novel gating modifier of Kv4.3 potassium channel from the scorpion toxin family.
Xie C; Li T; Xu L; Yu C; Cao Z; Li W; Wu Y
Biochem Biophys Res Commun; 2014 Feb; 444(3):406-10. PubMed ID: 24472546
[TBL] [Abstract][Full Text] [Related]
22. The role of PSD-95 in the rearrangement of Kv1.3 channels to the immunological synapse.
Szilágyi O; Boratkó A; Panyi G; Hajdu P
Pflugers Arch; 2013 Sep; 465(9):1341-53. PubMed ID: 23553419
[TBL] [Abstract][Full Text] [Related]
23. Unusual binding mode of scorpion toxin BmKTX onto potassium channels relies on its distribution of acidic residues.
Chen Z; Hu Y; Hu J; Yang W; Sabatier JM; De Waard M; Cao Z; Li W; Han S; Wu Y
Biochem Biophys Res Commun; 2014 Apr; 447(1):70-6. PubMed ID: 24704423
[TBL] [Abstract][Full Text] [Related]
24. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
Rodrigues AR; Arantes EC; Monje F; Stühmer W; Varanda WA
Br J Pharmacol; 2003 Jul; 139(6):1180-6. PubMed ID: 12871837
[TBL] [Abstract][Full Text] [Related]
25. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages.
Villalonga N; Escalada A; Vicente R; Sánchez-Tilló E; Celada A; Solsona C; Felipe A
Biochem Biophys Res Commun; 2007 Jan; 352(4):913-8. PubMed ID: 17157812
[TBL] [Abstract][Full Text] [Related]
26. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
[TBL] [Abstract][Full Text] [Related]
27. Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
Bartok A; Toth A; Somodi S; Szanto TG; Hajdu P; Panyi G; Varga Z
Toxicon; 2014 Sep; 87():6-16. PubMed ID: 24878374
[TBL] [Abstract][Full Text] [Related]
28. Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR.
Lange A; Giller K; Hornig S; Martin-Eauclaire MF; Pongs O; Becker S; Baldus M
Nature; 2006 Apr; 440(7086):959-62. PubMed ID: 16612389
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of cell-free expressed K
Cortes S; Barette C; Beroud R; De Waard M; Schaack B
Protein Expr Purif; 2018 May; 145():94-99. PubMed ID: 29366963
[TBL] [Abstract][Full Text] [Related]
30. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
[TBL] [Abstract][Full Text] [Related]
31. ImKTx1, a new Kv1.3 channel blocker with a unique primary structure.
Chen Z; Hu Y; Han S; Yin S; He Y; Wu Y; Cao Z; Li W
J Biochem Mol Toxicol; 2011; 25(4):244-51. PubMed ID: 21308893
[TBL] [Abstract][Full Text] [Related]
32. Expression and characterization of a novel scorpine-like peptide Ev37, from the scorpion Euscorpiops validus.
Feng J; Yu C; Wang M; Li Z; Wu Y; Cao Z; Li W; He X; Han S
Protein Expr Purif; 2013 Mar; 88(1):127-33. PubMed ID: 23262394
[TBL] [Abstract][Full Text] [Related]
33. Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes.
Gurrola GB; Hernández-López RA; Rodríguez de la Vega RC; Varga Z; Batista CV; Salas-Castillo SP; Panyi G; del Río-Portilla F; Possani LD
Biochemistry; 2012 May; 51(19):4049-61. PubMed ID: 22540187
[TBL] [Abstract][Full Text] [Related]
34. A potent potassium channel blocker from Mesobuthus eupeus scorpion venom.
Gao B; Peigneur S; Tytgat J; Zhu S
Biochimie; 2010 Dec; 92(12):1847-53. PubMed ID: 20713119
[TBL] [Abstract][Full Text] [Related]
35. Vietnamese Heterometrus laoticus scorpion venom: evidence for analgesic and anti-inflammatory activity and isolation of new polypeptide toxin acting on Kv1.3 potassium channel.
Hoang AN; Vo HD; Vo NP; Kudryashova KS; Nekrasova OV; Feofanov AV; Kirpichnikov MP; Andreeva TV; Serebryakova MV; Tsetlin VI; Utkin YN
Toxicon; 2014 Jan; 77():40-8. PubMed ID: 24189292
[TBL] [Abstract][Full Text] [Related]
36. The C-terminus SH3-binding domain of Kv1.3 is required for the actin-mediated immobilization of the channel via cortactin.
Hajdu P; Martin GV; Chimote AA; Szilagyi O; Takimoto K; Conforti L
Mol Biol Cell; 2015 May; 26(9):1640-51. PubMed ID: 25739456
[TBL] [Abstract][Full Text] [Related]
37. Free energy simulations of binding of HsTx1 toxin to Kv1 potassium channels: the basis of Kv1.3/Kv1.1 selectivity.
Rashid MH; Kuyucak S
J Phys Chem B; 2014 Jan; 118(3):707-16. PubMed ID: 24397610
[TBL] [Abstract][Full Text] [Related]
38. Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus.
Papp F; Batista CV; Varga Z; Herceg M; Román-González SA; Gaspar R; Possani LD; Panyi G
Toxicon; 2009 Sep; 54(4):379-89. PubMed ID: 19500613
[TBL] [Abstract][Full Text] [Related]
39. Mapping of maurotoxin binding sites on hKv1.2, hKv1.3, and hIKCa1 channels.
Visan V; Fajloun Z; Sabatier JM; Grissmer S
Mol Pharmacol; 2004 Nov; 66(5):1103-12. PubMed ID: 15286210
[TBL] [Abstract][Full Text] [Related]
40. Blockade action of ketanserin and increasing effect of potassium ion on Kv1.3 channels expressed in Xenopus oocytes.
Wang X; Liao Y; Zou A; Li L; Tu D
Pharmacol Res; 2007 Aug; 56(2):148-54. PubMed ID: 17582781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
